|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06185 CANSINOBIO
Nominal 
31.760 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 546,653 | 46.130% | 1,059,393 | 824,884 | 345,182 | 1,031,041 |
| Cost of Sales | (133,186) | 71.835% | (260,131) | (244,432) | (1,221,201) | (1,217,648) |
| Gross Profit | 413,467 | 39.412% | 799,262 | 580,452 | (876,019) | (186,607) |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (9,171) | -25.783% | (12,516) | (15,152) | (15,046) | (8,777) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (2,838) | 200.636% | (1,388) | (16,768) | 1,217 | 0 | |
| Profit / (Loss) before Taxation | 6,038 | -- | 21,738 | (381,204) | (1,978,884) | (1,184,001) | |
| Taxation | (6,759) | -- | 6,135 | (2,467) | 11,451 | 219,244 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 4,787 | 484,701 | 55,326 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (721) | -94.653% | 27,873 | (378,884) | (1,482,732) | (909,431) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 21,499 | 25.762% | 22,525 | (22,186) | (56,298) | (184,741) |
| Depreciation & Amortisation | 97,481 | 16.431% | 178,723 | 213,662 | 271,476 | 229,962 |
| Directors' Emoluments | -- | -- | 12,120 | 15,148 | 21,816 | 26,049 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -0.290 | -94.200% | 11.000 | -153.000 | -601.000 | -368.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.315 | (0.684) | (3.713) | (7.641) |
| NBV per share ($) | 20.150 | -- | 20.052 | 19.874 | 21.316 | 27.271 |
| Remarks: | Real time quote last updated: 31/08/2026 08:24 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -721 |
| %Change | -94.653% |
| EPS / (LPS) | RMB -0.003 |
| NBV Per Share (¥) | RMB 20.150 |